RE: RE: Promise21 Jan 2026 14:30
WB
Info via makemoremoney link on 18th Jan26
Number of Securities In Issue and Significant Shareholders
ImmuPharma has 502,723,932 ordinary shares of 1p each in issue, each of which entitles the holder to cast one vote in general meetings. The Company does not hold any Ordinary Shares in treasury. As at 6 January 2026, major shareholders, who have provided a TR1 to the Company, are detailed below:
Number of Ordinary 1p shares % of issued share capital
Luca & Associates AG 14,070,000 2.80%
Alora Pharmaceuticals (Avion) 10,909,091 2.17%
The holdings of Directors are as follows:
Tim McCarthy
(Chairman & Chief Executive Officer) 1,488,462 0.30%
Dr Tim Franklin
(Chief Operating Officer) 525,000 0.10%
Lisa Baderoon
(Non-Executive Director and Head of Investor Relations) 1,583,963 0.32%
Dr Sébastien R. Goudreau
(Chief Scientific Officer) 150,000 0.03%
As far as the Company is aware, the percentage of ImmuPharma’s issued share capital that is not in public hands is under 1%. This percentage comprises the holdings of Directors only.
ImmuPharma is subject to the UK City Code on Takeovers and Mergers.
Total Warrants and Options Outstanding
Total number of warrants outstanding = 98,042,350
Total number of options outstanding = 46,525,000